当前位置： SCI文献检索 > Retrovirology期刊下所有文献 > Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages.

Host mRNA decay proteins influence HIV-1 replication and viral gene expression in primary monocyte-derived macrophages.

Abstract：

BACKGROUND:Mammalian cells harbour RNA quality control and degradative machineries such as nonsense-mediated mRNA decay that target cellular mRNAs for clearance from the cell to avoid aberrant gene expression. The role of the host mRNA decay pathways in macrophages in the context of human immunodeficiency virus type 1 (HIV-1) infection is yet to be elucidated. Macrophages are directly infected by HIV-1, mediate the dissemination of the virus and contribute to the chronic activation of the inflammatory response observed in infected individuals. Therefore, we characterized the effects of four host mRNA decay proteins, i.e., UPF1, UPF2, SMG6 and Staufen1, on viral replication in HIV-1-infected primary monocyte-derived macrophages (MDMs). RESULTS:Steady-state expression levels of these host mRNA decay proteins were significantly downregulated in HIV-1-infected MDMs. Moreover, UPF2 and SMG6 inhibited HIV-1 gene expression in macrophages to a similar level achieved by SAMHD1, by directly influencing viral genomic RNA levels. Staufen1, a host protein also involved in UPF1-dependent mRNA decay and that acts at several HIV-1 replication steps, enhanced HIV-1 gene expression in MDMs. CONCLUSIONS:These results provide new evidence for roles of host mRNA decay proteins in regulating HIV-1 replication in infected macrophages and can serve as potential targets for broad-spectrum antiviral therapeutics.

journal_name

Retrovirology

journal_title

Retrovirology

authors

Rao S,Amorim R,Niu M,Breton Y,Tremblay MJ,Mouland AJ

doi

10.1186/s12977-019-0465-2

subject

Has Abstract

pub_date

2019-02-07 00:00:00

pages

3

issue

1

issn

1742-4690

pii

10.1186/s12977-019-0465-2

journal_volume

16

pub_type

杂志文章

相关文献

Retrovirology文献大全
  • Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

    abstract：BACKGROUND:Emergence of drug-resistant strains of human immunodeficiency virus type 1 (HIV-1) is a major obstacle to successful antiretroviral therapy (ART) in HIV-infected patients. Whether antiviral immunity can augment ART by suppressing replication of drug-resistant HIV-1 in humans is not well understood, but can b...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-3-97

    authors： Metzner KJ,Binley JM,Gettie A,Marx P,Nixon DF,Connor RI

    更新日期：2006-12-21 00:00:00

  • NHEJ pathway is involved in post-integrational DNA repair due to Ku70 binding to HIV-1 integrase.

    abstract：BACKGROUND:HIV-1 integration results in genomic DNA gaps that are repaired by cellular DNA repair pathways. This step of the lentiviral life cycle remains poorly understood despite its crucial importance for successful replication. We and others reported that Ku70 protein of the non-homologous end joining pathway (NHEJ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/s12977-019-0492-z

    authors： Knyazhanskaya E,Anisenko A,Shadrina O,Kalinina A,Zatsepin T,Zalevsky A,Mazurov D,Gottikh M

    更新日期：2019-11-06 00:00:00

  • STLV-1 as a model for studying HTLV-1 infection.

    abstract：:Few years after HTLV-1 identification and isolation in humans, STLV-1, its simian counterpart, was discovered. It then became clear that STLV-1 is present almost in all simian species. Subsequent molecular epidemiology studies demonstrated that, apart from HTLV-1 subtype A, all human subtypes have a simian homolog. As...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/s12977-019-0503-0

    authors： Jégado B,Kashanchi F,Dutartre H,Mahieux R

    更新日期：2019-12-16 00:00:00

  • Good CoP, bad CoP? Interrogating the immune responses to primate lentiviral vaccines.

    abstract：:Correlates of protection (CoPs) against infection by primate lentiviruses remain undefined. Modest protection against HIV-1 was observed in one human vaccine trial, whereas previous trials and vaccine-challenge experiments in non-human primates have yielded inconsistent but intriguing results. Although high levels of ...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/1742-4690-9-80

    authors： Klasse PJ,Moore JP

    更新日期：2012-10-01 00:00:00

  • An expanded model of HIV cell entry phenotype based on multi-parameter single-cell data.

    abstract：BACKGROUND:Entry of human immunodeficiency virus type 1 (HIV-1) into the host cell involves interactions between the viral envelope glycoproteins (Env) and the cellular receptor CD4 as well as a coreceptor molecule (most importantly CCR5 or CXCR4). Viral preference for a specific coreceptor (tropism) is in particular d...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-9-60

    authors： Bozek K,Eckhardt M,Sierra S,Anders M,Kaiser R,Kräusslich HG,Müller B,Lengauer T

    更新日期：2012-07-25 00:00:00

  • The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

    abstract：:HTLV-1 was the first described human retrovirus and was soon found to be associated with severe clinical diseases, including a devastating lymphoma/leukemia and other inflammatory diseases. Although HTLV-2 is not usually pathogenic, it is widely distributed among native Indian populations in Brazil, particularly in th...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/s12977-020-0512-z

    authors： Ishak R,de Oliveira Guimarães Ishak M,Vallinoto ACR

    更新日期：2020-02-14 00:00:00

  • Digital PCR as a tool to measure HIV persistence.

    abstract：:Although antiretroviral therapy is able to suppress HIV replication in infected patients, the virus persists and rebounds when treatment is stopped. In order to find a cure that can eradicate the latent reservoir, one must be able to quantify the persisting virus. Traditionally, HIV persistence studies have used real-...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/s12977-018-0399-0

    authors： Rutsaert S,Bosman K,Trypsteen W,Nijhuis M,Vandekerckhove L

    更新日期：2018-01-30 00:00:00

  • The expanding role of Tax in transcription.

    abstract：:The viral transactivator of HTLV-I, Tax, has long been shown to target the earliest steps of transcription by forming quaternary complexes with sequence specific transcription factors and histone-modifying enzymes in the LTR of HTLV-I. However, a new study suggests that Tax preferentially transactivates the 21-bp repe...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-1-19

    authors： de la Fuente C,Kashanchi F

    更新日期：2004-07-30 00:00:00

  • Natural APOBEC3C variants can elicit differential HIV-1 restriction activity.

    abstract：BACKGROUND:The APOBEC3 (A3) family of DNA cytosine deaminases provides an innate barrier to infection by retroviruses including HIV-1. A total of five enzymes, A3C, A3D, A3F, A3G and A3H, are degraded by the viral accessory protein Vif and expressed at high levels in CD4+ T cells, the primary reservoir for HIV-1 replic...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/s12977-018-0459-5

    authors： Anderson BD,Ikeda T,Moghadasi SA,Martin AS,Brown WL,Harris RS

    更新日期：2018-12-17 00:00:00

  • Longitudinal analysis of subtype C envelope tropism for memory CD4+ T cell subsets over the first 3 years of untreated HIV-1 infection.

    abstract：BACKGROUND:HIV-1 infects a wide range of CD4+ T cells with different phenotypic properties and differing expression levels of entry coreceptors. We sought to determine the viral tropism of subtype C (C-HIV) Envelope (Env) clones for different CD4+ T cell subsets and whether tropism changes during acute to chronic disea...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/s12977-020-00532-2

    authors： Gartner MJ,Gorry PR,Tumpach C,Zhou J,Dantanarayana A,Chang JJ,Angelovich TA,Ellenberg P,Laumaea AE,Nonyane M,Moore PL,Lewin SR,Churchill MJ,Flynn JK,Roche M

    更新日期：2020-08-06 00:00:00

  • Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients.

    abstract：BACKGROUND:Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-5-7

    authors： Kapoor A,Shapiro B,Shafer RW,Shulman N,Rhee SY,Delwart EL

    更新日期：2008-01-25 00:00:00

  • DBR1 siRNA inhibition of HIV-1 replication.

    abstract：BACKGROUND:HIV-1 and all retroviruses are related to retroelements of simpler organisms such as the yeast Ty elements. Recent work has suggested that the yeast retroelement Ty1 replicates via an unexpected RNA lariat intermediate in cDNA synthesis. The putative genomic RNA lariat intermediate is formed by a 2'-5' phosp...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-2-63

    authors： Ye Y,De Leon J,Yokoyama N,Naidu Y,Camerini D

    更新日期：2005-10-18 00:00:00

  • The silent defense: micro-RNA directed defense against HIV-1 replication.

    abstract：:MicroRNAs play critical role in regulating gene expression. MicroRNA profile of particular cell type bears the signature of cell type specific gene expression. Given that viral pathogens replicate by evading host defenses, research is now focused on the miRNA-regulated genes that critically regulate HIV-1 propagation ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-4-26

    authors： Kumar A

    更新日期：2007-04-12 00:00:00

  • TLR2 and TLR4 triggering exerts contrasting effects with regard to HIV-1 infection of human dendritic cells and subsequent virus transfer to CD4+ T cells.

    abstract：BACKGROUND:Recognition of microbial products through Toll-like receptors (TLRs) initiates inflammatory responses orchestrated by innate immune cells such as dendritic cells (DCs). As these cells are patrolling mucosal surfaces, a portal of entry for various pathogens including human immunodeficiency virus type-1 (HIV-1...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-6-42

    authors： Thibault S,Fromentin R,Tardif MR,Tremblay MJ

    更新日期：2009-05-06 00:00:00

  • The role of integration and clonal expansion in HIV infection: live long and prosper.

    abstract：:Integration of viral DNA into the host genome is a central event in the replication cycle and the pathogenesis of retroviruses, including HIV. Although most cells infected with HIV are rapidly eliminated in vivo, HIV also infects long-lived cells that persist during combination antiretroviral therapy (cART). Cells wit...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/s12977-018-0448-8

    authors： Anderson EM,Maldarelli F

    更新日期：2018-10-23 00:00:00

  • Reactivation of latent HIV-1 in central memory CD4⁺ T cells through TLR-1/2 stimulation.

    abstract：BACKGROUND:Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system. TLRs are present and functional in CD4⁺ T cells. Memory CD4⁺ T cells, predominantly central memory cells (TCM), constitute the main reservoir of latent HIV-1. However, how TL...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-10-119

    authors： Novis CL,Archin NM,Buzon MJ,Verdin E,Round JL,Lichterfeld M,Margolis DM,Planelles V,Bosque A

    更新日期：2013-10-24 00:00:00

  • Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.

    abstract：BACKGROUND:Mutations in the substrate of HIV-1 protease, especially changes in the NC/p1 cleavage site, can directly contribute to protease inhibitor (PI) resistance and also compensate for defects in viral replicative capacity (RC) due to a drug resistant protease. These NC/p1 changes are known to enhance processing o...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-9-29

    authors： van Maarseveen NM,Andersson D,Lepšík M,Fun A,Schipper PJ,de Jong D,Boucher CA,Nijhuis M

    更新日期：2012-04-01 00:00:00

  • Identification and characterization of diverse groups of endogenous retroviruses in felids.

    abstract：BACKGROUND:Endogenous retroviruses (ERVs) are genetic elements with a retroviral origin that are integrated into vertebrate genomes. In felids (Mammalia, Carnivora, Felidae), ERVs have been described mostly in the domestic cat, and only rarely in wild species. To gain insight into the origins and evolutionary dynamics ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/s12977-015-0152-x

    authors： Mata H,Gongora J,Eizirik E,Alves BM,Soares MA,Ravazzolo AP

    更新日期：2015-03-15 00:00:00

  • Microbial exposure alters HIV-1-induced mucosal CD4+ T cell death pathways Ex vivo.

    abstract：BACKGROUND:Early HIV-1 infection causes massive CD4+ T cell death in the gut and translocation of bacteria into the circulation. However, the programmed cell death (PCD) pathways used by HIV-1 to kill CD4+ T cells in the gut, and the impact of microbial exposure on T cell loss, remain unclear. Understanding mucosal HIV...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-11-14

    authors： Steele AK,Lee EJ,Manuzak JA,Dillon SM,Beckham JD,McCarter MD,Santiago ML,Wilson CC

    更新日期：2014-02-04 00:00:00

  • MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.

    abstract：BACKGROUND:Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to be highly conserved ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-9-36

    authors： Grupping K,Selhorst P,Michiels J,Vereecken K,Heyndrickx L,Kessler P,Vanham G,Martin L,Ariën KK

    更新日期：2012-05-02 00:00:00

  • Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

    abstract：:HIV viruses encode a set of accessory proteins, which are important determinants of virulence due to their ability to manipulate the host cell physiology for the benefit of the virus. Although these viral proteins are dispensable for viral growth in many in vitro cell culture systems, they influence the efficiency of ...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/1742-4690-7-35

    authors： Ayinde D,Maudet C,Transy C,Margottin-Goguet F

    更新日期：2010-04-09 00:00:00

  • 'Libyan Trial': a verdict running counter to scientific evidence.

    abstract：:Sidaction's appeal regarding the sentencing of medical personnels in the Libyan-HIV infection cases. ...

    journal_title：Retrovirology

    pub_type： 社论

    doi：10.1186/1742-4690-3-98

    authors： Fleutelot E

    更新日期：2006-12-27 00:00:00

  • Prolonged tenofovir treatment of macaques infected with K65R reverse transcriptase mutants of SIV results in the development of antiviral immune responses that control virus replication after drug withdrawal.

    abstract：BACKGROUND:We reported previously that while prolonged tenofovir monotherapy of macaques infected with virulent simian immunodeficiency virus (SIV) resulted invariably in the emergence of viral mutants with reduced in vitro drug susceptibility and a K65R mutation in reverse transcriptase, some animals controlled virus ...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-9-57

    authors： Van Rompay KK,Trott KA,Jayashankar K,Geng Y,LaBranche CC,Johnson JA,Landucci G,Lipscomb J,Tarara RP,Canfield DR,Heneine W,Forthal DN,Montefiori D,Abel K

    更新日期：2012-07-17 00:00:00

  • Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose.

    abstract：BACKGROUND:A key goal for HIV-1 envelope immunogen design is the induction of cross-reactive neutralizing antibodies (nAbs). As AIDS vaccine recipients will not be exposed to strains exactly matching any immunogens due to multiple HIV-1 quasispecies circulating in the human population worldwide, heterologous SHIV chall...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-11-8

    authors： Sholukh AM,Byrareddy SN,Shanmuganathan V,Hemashettar G,Lakhashe SK,Rasmussen RA,Watkins JD,Vyas HK,Thorat S,Brandstoetter T,Mukhtar MM,Yoon JK,Novembre FJ,Villinger F,Landucci G,Forthal DN,Ratcliffe S,Tuero I,Robert-G

    更新日期：2014-01-20 00:00:00

  • Emv2, the only endogenous ecotropic murine leukemia virus of C57BL/6J mice.

    abstract：:With the proliferation of sequence data, great challenges are posed in the correct annotation of endogenous retroviruses, which together comprise up to ten per cent of the genomes of many organisms. It is therefore essential that all sources of information are carefully considered before drawing conclusions concerning...

    journal_title：Retrovirology

    pub_type： 评论,信件

    doi：10.1186/1742-4690-9-23

    authors： Young GR,Kassiotis G,Stoye JP

    更新日期：2012-03-22 00:00:00

  • Genome-wide association studies on HIV susceptibility, pathogenesis and pharmacogenomics.

    abstract：:Susceptibility to HIV-1 and the clinical course after infection show a substantial heterogeneity between individuals. Part of this variability can be attributed to host genetic variation. Initial candidate gene studies have revealed interesting host factors that influence HIV infection, replication and pathogenesis. R...

    journal_title：Retrovirology

    pub_type： 杂志文章,评审

    doi：10.1186/1742-4690-9-70

    authors： van Manen D,van 't Wout AB,Schuitemaker H

    更新日期：2012-08-24 00:00:00

  • Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.

    abstract：BACKGROUND:The N-heptad repeat region of the HIV-1 Transmembrane Envelope protein is a trimerization domain that forms part of a "six helix bundle" crucial to Envelope-mediated membrane fusion. N-heptad repeat peptides have been used as extracellular reagents to inhibit virus fusion. RESULTS:When expressed intracellul...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-2-51

    authors： Ou W,Silver J

    更新日期：2005-08-10 00:00:00

  • H-index, mentoring-index, highly-cited and highly-accessed: how to evaluate scientists?

    abstract：:How best to evaluate scientists within a peer group is a difficult task. This editorial discusses the use of the H-index and total citations. It also raises the consideration of a mentoring-index and the value of understanding the frequency that a published paper is accessed by readers. ...

    journal_title：Retrovirology

    pub_type： 社论

    doi：10.1186/1742-4690-5-106

    authors： Jeang KT

    更新日期：2008-11-25 00:00:00

  • Transcriptional profiling reveals molecular signatures associated with HIV permissiveness in Th1Th17 cells and identifies peroxisome proliferator-activated receptor gamma as an intrinsic negative regulator of viral replication.

    abstract：BACKGROUND:We previously demonstrated that primary Th1Th17 cells are highly permissive to HIV-1, whereas Th1 cells are relatively resistant. Molecular mechanisms underlying these differences remain unknown. RESULTS:Exposure to replication competent and single-round VSV-G pseudotyped HIV strains provide evidence that s...

    journal_title：Retrovirology

    pub_type： 杂志文章

    doi：10.1186/1742-4690-10-160

    authors： Bernier A,Cleret-Buhot A,Zhang Y,Goulet JP,Monteiro P,Gosselin A,DaFonseca S,Wacleche VS,Jenabian MA,Routy JP,Tremblay C,Ancuta P

    更新日期：2013-12-21 00:00:00

  • Lipid levels, insulin resistance and cardiovascular risk over 96 weeks of antiretroviral therapy: a randomised controlled trial comparing low-dose stavudine and tenofovir.

    abstract：BACKGROUND:HIV infection and antiretroviral treatment are associated with changes in lipid levels, insulin resistance and risk of cardiovascular disease (CVD). We investigated these changes in the first 96 weeks of treatment with low-dose stavudine or tenofovir regimens. METHODS:This is a secondary analysis of a doubl...

    journal_title：Retrovirology

    pub_type： 杂志文章,随机对照试验

    doi：10.1186/s12977-018-0460-z

    authors： Vos AG,Chersich MF,Klipstein-Grobusch K,Zuithoff P,Moorhouse MA,Lalla-Edward ST,Kambugu A,Kumarasamy N,Grobbee DE,Barth RE,Venter WD

    更新日期：2018-12-14 00:00:00